Sulfalene: Difference between revisions

Revision as of 05:08, 26 August 2011 editCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - updated 'ChEMBL_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot← Previous edit		Revision as of 05:22, 26 August 2011 edit undoBomazi (talk \| contribs)Extended confirmed users3,446 editsNo edit summaryNext edit →
Line 29:		Line 29:
	\| legal_status =		\| legal_status =
	\| dependency_liability =		\| dependency_liability =
			\| routes_of_administration = Oral<ref name="MIMS">{{cite web \|url=http://www.cimsasia.com/USA/drug/info/sulfalene/?q=Sulphonamides&type=full \|title=Sulfalene \|work=MIMS Drug Information System \|accessdate=26 August 2011}}</ref>
	\| routes_of_administration = Oral

	<!--Pharmacokinetic data-->		<!--Pharmacokinetic data-->
	\| bioavailability =		\| bioavailability =
	\| protein_bound =		\| protein_bound = 60 to 80%<ref name="MIMS"/>
	\| metabolism =		\| metabolism =
	\| elimination_half-life =		\| elimination_half-life = 60 to 65 hours<ref name="MIMS"/>
	\| excretion =		\| excretion = ]<ref name="MIMS"/>

	<!--Identifiers-->		<!--Identifiers-->

Revision as of 05:22, 26 August 2011

Pharmaceutical compound

Sulfalene
Clinical data

Other names	Sulfametopyrazine
Routes of administration	Oral
ATC code	J01ED02 (WHO)
Pharmacokinetic data
Protein binding	60 to 80%
Elimination half-life	60 to 65 hours
Excretion	Urinary
Identifiers
IUPAC name 4-Amino-N-(3-methoxypyrazinyl)benzenesulfonamide
CAS Number	152-47-6
PubChem CID	9047
DrugBank	DB00664
ChemSpider	8695
UNII	T6BL4ZC15G
KEGG	D01216
CompTox Dashboard (EPA)	DTXSID2046179
ECHA InfoCard	100.005.278
Chemical and physical data
Formula	C₁₁H₁₂N₄O₃S
Molar mass	280.304 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES O=S(=O)(Nc1nccnc1OC)c2ccc(N)cc2
InChI InChI=1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15) Key:KXRZBTAEDBELFD-UHFFFAOYSA-N
(verify)

Sulfalene is a sulfonamide antibacterial used for the treatment of chronic bronchitis, urinary tract infections and malaria.

Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)

Short-acting	Sulfaisodimidine Sulfamethizole Sulfadimidine (Sulfamethazine, Sulfadimerazine, Sulfadimezine) Sulfapyridine (Sulfasalazine) Sulfafurazole (Acetyl sulfisoxazole) Sulfanilamide Prontosil Sulfathiazole (Phthalylsulfathiazole, Succinylsulfathiazole) Sulfathiourea
Intermediate-acting	Sulfamethoxazole Sulfadiazine Sulfamoxole
Long-acting	Sulfadimethoxine Sulfadoxine Sulfalene Sulfametomidine Sulfametoxydiazine Sulfamethoxypyridazine Sulfaperin Sulfamerazine Sulfaphenazole Sulfamazone
Other/ungrouped	Mafenide Sulfacetamide Sulfaclozine Sulfadicramide Sulfaguanidine Sulfametrole Sulfanitran

Combinations

Other DHPS inhibitors

Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)

2nd generation	Ciprofloxacin Ofloxacin Enoxacin Fleroxacin Lomefloxacin Nadifloxacin/Levonadifloxacin/Alalevonadifloxacin Norfloxacin Pefloxacin Rufloxacin
3rd generation	Levofloxacin Balofloxacin Grepafloxacin Pazufloxacin Sparfloxacin Temafloxacin Tosufloxacin
4th generation	Besifloxacin Delafloxacin Gatifloxacin Finafloxacin Gemifloxacin Moxifloxacin Clinafloxacin Garenoxacin Prulifloxacin Sitafloxacin Trovafloxacin/Alatrofloxacin
Veterinary	Danofloxacin Difloxacin Enrofloxacin Ibafloxacin Marbofloxacin Orbifloxacin Pradofloxacin Sarafloxacin

Newer non-fluorinated

Related (DG)

Nitroimidazole derivatives	Secnidazole

RNA synthesis

Rifamycins/ RNA polymerase	Rifampicin Rifabutin Rifapentine Rifaximin Rifalazil
Lipiarmycins	Fidaxomicin

This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it.